|
|
|
40
|
B1516
|
ELIQUIS 2.5MG TAB (PFI/STO) APIXABAN
|
APIXABAN
|
ELIQUIS
|
60'S
|
C
|
219.40
|
3.66
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1516
|
ELIQUIS 2.5MG TAB (PFI) APIXABAN (B)
|
APIXABAN
|
ELIQUIS
|
60'S
|
B
|
175.33
|
2.9222
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
40
|
B1526
|
ELIQUIS 5MG TAB (PFI/STO) APIXABAN
|
APIXABAN
|
ELIQUIS
|
60'S
|
C
|
219.40
|
3.66
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
B1526
|
ELIQUIS 5MG TAB (PFI) APIXABAN (B)
|
APIXABAN
|
ELIQUIS
|
60'S
|
B
|
175.33
|
2.9222
|
TAB
|
60
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
20120412
|
DIRECT THROMBIN INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT THROMBIN INHIBITORS
|
|